55 related articles for article (PubMed ID: 11559722)
1. Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series.
Russo I; Marino D; Cozzolino C; Del Fiore P; Nerjaku F; Finotto S; Cattelan A; Calabrò ML; Belloni Fortina A; Russano F; Mazza M; Galuppo S; Bezzon E; Sbaraglia M; Krengli M; Brunello A; Mocellin S; Piaserico S; Alaibac M
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398082
[TBL] [Abstract][Full Text] [Related]
2. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
Volkow P; Chavez Galan L; Ramon-Luing L; Cruz-Velazquez J; Cornejo-Juarez P; Sada-Ovalle I; Perez-Padilla R; Islas-Muñoz B;
PLoS One; 2023; 18(5):e0280209. PubMed ID: 37195970
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in HIV-associated Kaposi sarcoma.
Dalla Pria A; Pinato DJ; Bracchi M; Bower M
F1000Res; 2019; 8():. PubMed ID: 31297181
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome-associated disseminated Kaposi's sarcoma in a patient infected with human immunodeficiency virus: Report of an autopsy case.
Cheng CH; Hsu YH
Ci Ji Yi Xue Za Zhi; 2017; 29(1):41-45. PubMed ID: 28757763
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract][Full Text] [Related]
6. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
[TBL] [Abstract][Full Text] [Related]
7. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
8. NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.
Barry JN; Vertegel AA
Nano Life; 2013 Dec; 3(4):. PubMed ID: 25414730
[TBL] [Abstract][Full Text] [Related]
9. Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma.
Arruda É; Jacome AA; Toscano AL; Silvestrini AA; Rêgo AS; Wiermann EG; Cunha GF; Melo HR; Morejón KM; Goldani LZ; Pereira LC; Silva MH; Treistman MS; Pereira MC; Romero PM; Schmerling RA; Guedes RA; Camargo VP
Braz J Infect Dis; 2014; 18(3):315-26. PubMed ID: 24525061
[TBL] [Abstract][Full Text] [Related]
10. Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy.
Baldini F; Baiocchini A; Schininà V; Agrati C; Giancola ML; Alba L; Grisetti S; Del Nonno F; Capobianchi MR; Antinori A
BMC Infect Dis; 2013 Dec; 13():600. PubMed ID: 24359263
[TBL] [Abstract][Full Text] [Related]
11. Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007.
Zeichner SB; Ruiz AL; Suciu GP; Zeichner RL; Rodriguez E
ISRN Oncol; 2012; 2012():642106. PubMed ID: 23320191
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Kaposi sarcoma in AIDS.
Hoskote SS; Patel VP
Mayo Clin Proc; 2012 Oct; 87(10):e77. PubMed ID: 23036685
[No Abstract] [Full Text] [Related]
13. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
Nguyen HQ; Magaret AS; Kitahata MM; Van Rompaey SE; Wald A; Casper C
AIDS; 2008 May; 22(8):937-45. PubMed ID: 18453853
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
Thomas M; Boname JM; Field S; Nejentsev S; Salio M; Cerundolo V; Wills M; Lehner PJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1656-61. PubMed ID: 18230726
[TBL] [Abstract][Full Text] [Related]
15. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.
Feller L; Lemmer J
Infect Agent Cancer; 2008 Jan; 3():1. PubMed ID: 18208585
[TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.
Dhasmana DJ; Dheda K; Ravn P; Wilkinson RJ; Meintjes G
Drugs; 2008; 68(2):191-208. PubMed ID: 18197725
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of KSHV in relation to AIDS-associated oncogenesis.
Greene W; Kuhne K; Ye F; Chen J; Zhou F; Lei X; Gao SJ
Cancer Treat Res; 2007; 133():69-127. PubMed ID: 17672038
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with HIV in the intensive care unit.
Masur H
Proc Am Thorac Soc; 2006; 3(1):96-102. PubMed ID: 16493156
[TBL] [Abstract][Full Text] [Related]
19. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
Holkova B; Takeshita K; Cheng DM; Volm M; Wasserheit C; Demopoulos R; Chanan-Khan A
J Clin Oncol; 2001 Sep; 19(18):3848-51. PubMed ID: 11559722
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
